Chen et al. (2013) also found that epidermal growth factor (ProEGF) was significantly decreased in bladder cancer patients, whereas serum amyloid A4 (SAA4) was significantly increased, when comparing hernia and bladder cancer patients [44]. Here, EGF is linked to urinary bladder cancer.